» Articles » PMID: 32829577

Application of Next Generation Sequencing in Laboratory Medicine

Overview
Journal Ann Lab Med
Specialty Pathology
Date 2020 Aug 25
PMID 32829577
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

The rapid development of next-generation sequencing (NGS) technology, including advances in sequencing chemistry, sequencing technologies, bioinformatics, and data interpretation, has facilitated its wide clinical application in precision medicine. This review describes current sequencing technologies, including short- and long-read sequencing technologies, and highlights the clinical application of NGS in inherited diseases, oncology, and infectious diseases. We review NGS approaches and clinical diagnosis for constitutional disorders; summarize the application of U.S. Food and Drug Administration-approved NGS panels, cancer biomarkers, minimal residual disease, and liquid biopsy in clinical oncology; and consider epidemiological surveillance, identification of pathogens, and the importance of host microbiome in infectious diseases. Finally, we discuss the challenges and future perspectives of clinical NGS tests.

Citing Articles

Recent advances in the methods and clinical applications of next-generation sequencing in genomic profiling and precision cancer therapy.

Alsaiari A EXCLI J. 2025; 24:15-33.

PMID: 39967910 PMC: 11830917. DOI: 10.17179/excli2024-7594.


Evaluation of nationwide analysis surveillance for methicillin-resistant within Genomic Medicine Sweden.

Tang Hallback E, Bjorkman J, Dyrkell F, Welander J, Fang H, Sylvin I Microb Genom. 2025; 11(1).

PMID: 39869391 PMC: 11893271. DOI: 10.1099/mgen.0.001331.


The role of metagenomic next-generation sequencing in diagnosing and managing post-kidney transplantation infections.

Wu H, Cao H, Gao X, Shi C, Wang L, Gao B Front Cell Infect Microbiol. 2025; 14():1473068.

PMID: 39839264 PMC: 11747774. DOI: 10.3389/fcimb.2024.1473068.


Diagnosis value of targeted and metagenomic sequencing in respiratory tract infection.

Kuang Y, Tan W, Hu C, Dai Z, Bai L, Wang J Front Cell Infect Microbiol. 2024; 14:1498512.

PMID: 39723191 PMC: 11669359. DOI: 10.3389/fcimb.2024.1498512.


Utility of p53 Immunohistochemical Staining for Risk Stratification of Mantle Cell Lymphoma.

Elsharawi I, Selegean S, Carter M J Hematol. 2024; 13(5):200-206.

PMID: 39493604 PMC: 11526585. DOI: 10.14740/jh1333.


References
1.
Mongkolrattanothai K, Naccache S, Bender J, Samayoa E, Pham E, Yu G . Neurobrucellosis: Unexpected Answer From Metagenomic Next-Generation Sequencing. J Pediatric Infect Dis Soc. 2017; 6(4):393-398. PMC: 6251619. DOI: 10.1093/jpids/piw066. View

2.
Dufour A, Schneider F, Metzeler K, Hoster E, Schneider S, Zellmeier E . Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. J Clin Oncol. 2009; 28(4):570-7. DOI: 10.1200/JCO.2008.21.6010. View

3.
Tamma P, Fan Y, Bergman Y, Pertea G, Kazmi A, Lewis S . Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates. Antimicrob Agents Chemother. 2018; 63(1). PMC: 6325187. DOI: 10.1128/AAC.01923-18. View

4.
Zhou J, He Z, Yang Y, Deng Y, Tringe S, Alvarez-Cohen L . High-throughput metagenomic technologies for complex microbial community analysis: open and closed formats. mBio. 2015; 6(1). PMC: 4324309. DOI: 10.1128/mBio.02288-14. View

5.
Tzou P, Ariyaratne P, Varghese V, Lee C, Rakhmanaliev E, Villy C . Comparison of an Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing. J Clin Microbiol. 2018; 56(6). PMC: 5971553. DOI: 10.1128/JCM.00105-18. View